Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Arthritis Rheumatol ; 68(8): 1839-48, 2016 08.
Article in English | MEDLINE | ID: mdl-26882526

ABSTRACT

OBJECTIVE: While the regulatory role of individual microRNAs (miRNAs) in rheumatoid arthritis (RA) is well established, the role of DICER1 in the pathogenesis of the disease has not yet been investigated. The purpose of this study was to analyze the expression of factors involved in miRNA biogenesis in fibroblast-like synoviocytes (FLS) from RA patients and to monitor the arthritis triggered by K/BxN serum transfer in mice deficient in the Dicer gene (Dicer(d/d) ). METHODS: The expression of genes and precursor miRNAs was quantified by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). MicroRNA macroarray profiling was monitored by qRT-PCR. Cytokines were quantified by enzyme-linked immunosorbent assay. Experimental arthritis in mice was achieved by the transfer of serum from K/BxN donors. Apoptosis was quantified using an enzyme-linked immunosorbent assay. RESULTS: We found decreased DICER1 and mature miRNA expression in synovial fibroblasts from RA patients. These cells were hyperresponsive to lipopolysaccharide, as evidenced by their increased interleukin-6 secretion upon stimulation. Experimental serum-transfer arthritis in Dicer(d/d) mice confirmed that an unbalanced biogenesis of miRNAs correlated with an enhanced inflammatory response. Synoviocytes from both RA patients and Dicer(d/d) mice exhibited increased resistance to apoptotic stimuli. CONCLUSION: The findings of this study further substantiate the important role of DICER1 in the maintenance of homeostasis and the regulation of inflammatory responses.


Subject(s)
Arthritis, Rheumatoid/genetics , DEAD-box RNA Helicases/genetics , Ribonuclease III/genetics , Synoviocytes/physiology , Animals , Apoptosis , Gene Expression Regulation , Humans , Inflammation/genetics , Mice
2.
J Autoimmun ; 56: 1-11, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25441030

ABSTRACT

Idiopathic pulmonary fibrosis (IPF) is a progressive devastating, yet untreatable fibrotic disease of unknown origin. We investigated the contribution of the B-cell activating factor (BAFF), a TNF family member recently implicated in the regulation of pathogenic IL-17-producing cells in autoimmune diseases. The contribution of BAFF was assessed in a murine model of lung fibrosis induced by airway administered bleomycin. We show that murine BAFF levels were strongly increased in the bronchoalveolar space and lungs after bleomycin exposure. We identified Gr1(+) neutrophils as an important source of BAFF upon BLM-induced lung inflammation and fibrosis. Genetic ablation of BAFF or BAFF neutralization by a soluble receptor significantly attenuated pulmonary fibrosis and IL-1ß levels. We further demonstrate that bleomycin-induced BAFF expression and lung fibrosis were IL-1ß and IL-17A dependent. BAFF was required for rIL-17A-induced lung fibrosis and augmented IL-17A production by CD3(+) T cells from murine fibrotic lungs ex vivo. Finally we report elevated levels of BAFF in bronchoalveolar lavages from IPF patients. Our data therefore support a role for BAFF in the establishment of pulmonary fibrosis and a crosstalk between IL-1ß, BAFF and IL-17A.


Subject(s)
Antibiotics, Antineoplastic/adverse effects , B-Cell Activating Factor/metabolism , Bleomycin/adverse effects , Idiopathic Pulmonary Fibrosis/etiology , Interleukin-17/metabolism , Animals , Antibiotics, Antineoplastic/administration & dosage , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/pharmacology , B-Cell Activating Factor/antagonists & inhibitors , B-Cell Activating Factor/deficiency , B-Cell Activating Factor/genetics , Bleomycin/administration & dosage , Bronchoalveolar Lavage Fluid , Disease Models, Animal , Fibrosis , Gene Expression , Idiopathic Pulmonary Fibrosis/pathology , Interleukin-17/genetics , Interleukin-1beta/metabolism , Lung/drug effects , Lung/metabolism , Lung/pathology , Mice , Mice, Knockout , Neutrophils/immunology , Neutrophils/metabolism , Signal Transduction/drug effects , T-Lymphocytes/immunology , T-Lymphocytes/metabolism
3.
PLoS One ; 9(10): e111266, 2014.
Article in English | MEDLINE | ID: mdl-25360821

ABSTRACT

We evaluated micro (mi) RNA-mediated regulation of BAFF expression in fibroblasts using two concomitant models: (i) synovial fibroblasts (FLS) isolated from healthy controls (N) or Rheumatoid Arthritis (RA) patients; (ii) human dermal fibroblasts (HDF) isolated from healthy controls (N) or Systemic Sclerosis (SSc) patients. Using RT-qPCR and ELISA, we first showed that SScHDF synthesized and released BAFF in response to Poly(I:C) or IFN-γ treatment, as previously observed in RAFLS, whereas NHDF released BAFF preferentially in response to IFN-γ. Next, we demonstrated that miR-30a-3p expression was down regulated in RAFLS and SScHDF stimulated with Poly(I:C) or IFN-γ. Moreover, we demonstrated that transfecting miR-30a-3p mimic in Poly(I:C)- and IFN-γ-activated RAFLS and SScHDF showed a strong decrease on BAFF synthesis and release and thus B cells survival in our model. Interestingly, FLS and HDF isolated from healthy subjects express higher levels of miR-30a-3p and lower levels of BAFF than RAFLS and SScHDF. Transfection of miR-30a-3p antisense in Poly(I:C)- and IFN-γ-activated NFLS and NHDF upregulated BAFF secretion, confirming that this microRNA is a basal repressors of BAFF expression in cells from healthy donors. Our data suggest a critical role of miR-30a-3p in the regulation of BAFF expression, which could have a major impact in the regulation of the autoimmune responses occurring in RA and SSc.


Subject(s)
Arthritis, Rheumatoid/genetics , Arthritis, Rheumatoid/pathology , B-Cell Activating Factor/biosynthesis , Fibroblasts/metabolism , MicroRNAs/genetics , Scleroderma, Systemic/genetics , Scleroderma, Systemic/pathology , 3' Untranslated Regions/genetics , Arthritis, Rheumatoid/immunology , B-Cell Activating Factor/genetics , B-Lymphocytes/cytology , B-Lymphocytes/drug effects , Base Sequence , Cell Survival/drug effects , Down-Regulation/drug effects , Down-Regulation/genetics , Female , Fibroblasts/drug effects , Humans , Interferon-gamma/pharmacology , Male , Middle Aged , Poly I-C/pharmacology , Scleroderma, Systemic/immunology
4.
Arthritis Res Ther ; 15(5): R168, 2013 Oct 28.
Article in English | MEDLINE | ID: mdl-24289101

ABSTRACT

INTRODUCTION: B lymphocytes might play a pathogenic role in dermal fibrosis in systemic sclerosis (SSc). B-cell activating factor (BAFF), a key cytokine for B-cell activation, is increased in the serum and the skin of patients with SSc. However, the ability of B cells directly to stimulate dermal fibroblasts and the role of BAFF are not fully understood. We therefore investigated the involvement of B cells and BAFF in the expression of collagen and profibrotic markers by dermal fibroblasts. METHODS: Cocultures of blood B cells from healthy blood donors and normal or SSc dermal fibroblasts stimulated with anti-IgM and BAFF were performed. Alpha-SMA, TIMP1, MMP9, COL1A1, COL1A2, and COL3A1 mRNA expression were determined by quantitative RT-PCR. Soluble collagen, BAFF, IL-6, IL-1ß, TGF-ß1, and CCL2 protein secretion were assessed. RESULTS: Coculture of blood B cells and dermal fibroblasts isolated from SSc patients induced IL-6, TGF-ß1, CCL2, and collagen secretion, as well as Alpha-SMA, TIMP1, and MMP9 expression in dermal fibroblasts. Transwell assays demonstrated that this induction was dependent on cell-cell contact. Addition of anti-IgM and BAFF to the coculture increased IL-6, CCL2, TGF-ß1, and collagen secretion. B cell- and BAFF-induced collagen secretion was highly reduced by anti-TGF-ß1 antibodies. CONCLUSIONS: Our results showed for the first time a direct role of B cells on the production of collagen by dermal fibroblasts, which is further enhanced by BAFF. Thus, these results demonstrate a new pathogenic role of B cells and BAFF in fibrosis and systemic sclerosis.


Subject(s)
B-Cell Activating Factor/immunology , B-Lymphocytes/immunology , Collagen/immunology , Fibroblasts/immunology , Actins/genetics , Actins/immunology , Actins/metabolism , Antibodies, Anti-Idiotypic/immunology , Antibodies, Anti-Idiotypic/pharmacology , B-Cell Activating Factor/metabolism , B-Cell Activating Factor/pharmacology , B-Lymphocytes/cytology , B-Lymphocytes/metabolism , Cells, Cultured , Chemokine CCL2/immunology , Chemokine CCL2/metabolism , Coculture Techniques , Collagen/genetics , Collagen/metabolism , Enzyme-Linked Immunosorbent Assay , Fibroblasts/metabolism , Fibroblasts/pathology , Fibrosis/genetics , Fibrosis/immunology , Fibrosis/metabolism , Gene Expression/drug effects , Gene Expression/immunology , Humans , Immunoglobulin M/immunology , Interleukin-6/immunology , Interleukin-6/metabolism , Matrix Metalloproteinase 9/genetics , Matrix Metalloproteinase 9/immunology , Muscle, Smooth/chemistry , Reverse Transcriptase Polymerase Chain Reaction , Scleroderma, Systemic/genetics , Scleroderma, Systemic/immunology , Scleroderma, Systemic/metabolism , Skin/immunology , Skin/metabolism , Skin/pathology , Tissue Inhibitor of Metalloproteinase-1/genetics , Tissue Inhibitor of Metalloproteinase-1/immunology , Transforming Growth Factor beta1/immunology , Transforming Growth Factor beta1/metabolism
5.
Eur J Immunol ; 41(7): 2113-22, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21557212

ABSTRACT

Fibroblast-like synoviocytes (FLSs) are important actors in rheumatoid arthritis (RA) pathogenesis. The autoimmune nature of RA is attributed to autoantibody production, which confers to B cells a predominant role in RA. Several arguments support an induction of class switch recombination (CSR) in RA synovium, causing--in conjunction with somatic hypermutation--the production of potentially pathogenic IgG. To determine whether RA FLSs can directly promote CSR and to analyze the role of external factors like TLR signals and BAFF (B cell activating factor) family cytokines in this FLS-B cell crosstalk, we performed cocultures of blood B cells (from normal individuals or RA patients) with RA FLSs and analyzed CSR induction by quantification of AICDA (encoding activation-induced cytidine deaminase, AID) and switch circular transcripts expression, and IgG secretion. RA FLSs--and to a lesser extent osteoarthritis or control FLSs--promoted CSR, and TLR3 stimulation potentialized it. In addition, induction of CSR by RA FLSs was totally dependent on cell-cell contact in basal conditions, and partially dependent in the case of TLR3 stimulation. Finally, we showed that the mechanism by which RA FLSs induce CSR is mostly BAFF-dependent. Our results support the hypothesis that CSR can be induced outside the ectopic lymphoid structures in RA.


Subject(s)
Arthritis, Rheumatoid/immunology , B-Cell Activating Factor/metabolism , Immunoglobulin Class Switching , Immunoglobulin G/biosynthesis , Synovial Membrane/cytology , Arthritis, Rheumatoid/pathology , Autoantibodies/biosynthesis , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Cells, Cultured , Coculture Techniques , Cytidine Deaminase/metabolism , Enzyme-Linked Immunosorbent Assay , Fibroblasts/metabolism , Humans , Immunoglobulin G/metabolism , Immunoglobulin Switch Region , Osteoarthritis/immunology , Osteoarthritis/pathology , Polymerase Chain Reaction , Somatic Hypermutation, Immunoglobulin , Synovial Membrane/metabolism , Toll-Like Receptor 3/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...